Jade Biosciences provides updated corporate presentation; no material new details disclosed

Jade Biosciences, Inc.

Company changed name from Aerovate Therapeutics to Jade Biosciences, effective prior to this filing; trades under ticker JBIO on Nasdaq.
Updated corporate presentation posted on company website on April 29, 2025; no financial or operational updates provided in the 8-K or exhibit.
Presentation appears to be a Company Overview slide with disclaimers; no new specific data (revenue, pipeline, guidance) disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.